The tetraamine chelator outperforms hynic in a new technetium-99m-labelled somatostatin receptor 2 antagonist

HIGHLIGHTS

• who: Keelara Abiraj from the Divisions of Radiopharmaceutical Chemistry and Nuclear Medicine, University Hospital Basel, Petersgraben, Basel, Switzerland have published the paper: The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist, in the Journal: (JOURNAL) of 01,/09/2007
• what: The authors report on a new subtype 2 (sst2) antagonist SS-01 (p-Cl-Phe-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)D-Tyr-NH2) with aim of developing 99mTc-labelled ligands for imaging. The authors report here the synthesis of a new somatostatin-based antagonist, 4 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.